| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 885 | 1.844 | 9.020 | 12.942 | 13.193 | 15.323 |
| Total Income - EUR | - | - | - | - | 885 | 1.844 | 9.020 | 13.058 | 13.193 | 15.323 |
| Total Expenses - EUR | - | - | - | - | 23 | 176 | 1.157 | 1.443 | 2.562 | 2.021 |
| Gross Profit/Loss - EUR | - | - | - | - | 863 | 1.668 | 7.863 | 11.615 | 10.631 | 13.302 |
| Net Profit/Loss - EUR | - | - | - | - | 836 | 1.615 | 7.616 | 11.302 | 9.097 | 11.204 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dr. Tudor Hemato S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 75 | 73 | 1.015 | 1.547 | 2.626 | 1.967 |
| Current Assets | - | - | - | - | 1.086 | 1.959 | 7.026 | 11.539 | 15.819 | 10.026 |
| Inventories | - | - | - | - | 183 | 180 | 176 | 176 | 176 | 175 |
| Receivables | - | - | - | - | 89 | 168 | 260 | 974 | 2.023 | 764 |
| Cash | - | - | - | - | 814 | 1.611 | 6.590 | 10.389 | 13.620 | 9.087 |
| Shareholders Funds | - | - | - | - | 878 | 1.677 | 7.680 | 12.888 | 18.308 | 11.317 |
| Social Capital | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Debts | - | - | - | - | 282 | 355 | 361 | 199 | 137 | 676 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dr. Tudor Hemato S.r.l.